Health

U.S. set to purchase another 180 million COVID-19 rapid tests – National

The U.S. government is committing to purchase an additional 180 million rapid COVID-19 tests for $1 billion, adding to the $2 billion test buying plan it announced in September, a top U.S. health official said on Wednesday.

The combined purchases will help quadruple the United States’ test output by December to around 200 million tests per month, Jeff Zients, the White House coronavirus response coordinator, said during a press call.

Read more:
Canada must be ‘practical’ on school rapid testing amid U.S. supply crunch: advocates

“We’ll continue to pull every lever to expand manufacturing production of tests which will have the impact of driving down the cost per test and making sure that tests are widely available and convenient,” Zients said.

The government will also double the number of pharmacies it partners with to provide free COVID-19 tests to 20,000 pharmacies, Zients added.

Story continues below advertisement


Click to play video: 'How to take a COVID-19 rapid test'







How to take a COVID-19 rapid test


How to take a COVID-19 rapid test – Sep 29, 2021

Surging demand for COVID-19 tests from U.S. employers has exacerbated a nationwide shortage of rapid tests in recent weeks and is driving up costs for state and local testing programs.

The White House in September said it plans to mandate weekly testing for unvaccinated staff at businesses with more than 100 employees.

Read more:
Ontario announces ‘targeted’ COVID-19 rapid test program in schools

The U.S. government agreed in September to purchase $2 billion worth of rapid COVID-19 tests from Abbott Laboratories and Celltrion Inc to ship to nursing homes and other high risk populations as part of President Joe Biden’s plans to increase vaccinations and tests.

The U.S. government also has agreements to purchase tests from other manufacturers, including Quidel Corp., OraSure Technologies, and Intrivo.

Story continues below advertisement


Click to play video: 'Frustration growing among people waiting for COVID-19 test'







Frustration growing among people waiting for COVID-19 test


Frustration growing among people waiting for COVID-19 test

Earlier this week, U.S. regulators authorized another rapid test from Acon Technologies that can be taken at home. Zients said the test will retail for around $10 per test.

The average number of daily U.S. coronavirus cases dropped by 12% over the last seven days to nearly 98,000, and hospitalizations dropped 14% to 7,400, said U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky said during the briefing.

She cautioned that deaths remained constant at 1,400 per day.

Reporting by Carl O’Donnell; Editing by Leslie Adler and Aurora Ellis




Read more

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button